|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.16 NZD | -2.17% |
|
+0.32% | -9.71% |
| 06-04 | New Zealand Shares Flat; Scott Technology Adds Meat Cutter to Brand Portfolio | MT |
| 06-03 | AFT Pharmaceuticals Partners with Alexso to Bring Pain Relief Drug to US Market | MT |
AFT Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was NZD 195.41 million compared to NZD 156.64 million a year ago. Net income was NZD 15.61 million compared to NZD 10.65 million a year ago.
Basic earnings per share from continuing operations was NZD 0.15 compared to NZD 0.1 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.71% | 203M | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B | |
| -4.38% | 156B |
AFT PHARMACEUTICALS LIMITED 
